{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:27:50Z","timestamp":1790670470014,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002943","name":"Departament d'Innovaci\u00f3, Universitats i Empresa, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["FI\/AGAUR-15"],"award-info":[{"award-number":["FI\/AGAUR-15"]}],"id":[{"id":"10.13039\/501100002943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dose of\n                    <jats:italic>Trp53<\/jats:italic>\n                    , the main keeper of genome stability, influences tumorigenesis; however, the causes underlying and driving tumorigenesis over time by the loss of a single p53 allele are still poorly characterized. Here, we found that single p53 allele loss specifically impacted the oxidative, DNA damage and inflammatory status of hematopoietic lineages. In particular, single\n                    <jats:italic>Trp53<\/jats:italic>\n                    allele loss in mice triggered oxidative stress in peripheral blood granulocytes and spleenocytes, whereas lack of two\n                    <jats:italic>Trp53<\/jats:italic>\n                    alleles produced enhanced oxidative stress in thymus cells, resulting in a higher incidence of lymphomas in the\n                    <jats:italic>Trp53<\/jats:italic>\n                    knockout (KO) mice compared with hemizygous (HEM). In addition, single or complete loss of\n                    <jats:italic>Trp53<\/jats:italic>\n                    alleles, as well as p53 downregulation, led to a differential increase in basal, LPS- and UVB-induced expression of a plethora of pro-inflammatory cytokine, such as interleukin-12 (\n                    <jats:italic>Il-12a<\/jats:italic>\n                    ), TNF\u03b1 (\n                    <jats:italic>Tnfa<\/jats:italic>\n                    ) and interleukin (\n                    <jats:italic>Il-23a<\/jats:italic>\n                    ) in bone marrow-derived macrophage cells (BMDMs) compared to WT cells. Interestingly, p53-dependent increased inflammatory gene expression correlated with deregulated expression of the NF-\u03baB pathway inhibitor I\u03baB\u03b1. Chromatin immunoprecipitation data revealed decreased p65 binding to\n                    <jats:italic>Nfkbia<\/jats:italic>\n                    in the absence of p53 and p53 binding to\n                    <jats:italic>Nfkbia<\/jats:italic>\n                    promoter, uncovering a novel crosstalk mechanism between p53 and NF-\u03baB transcription factors. Overall, our data suggest that single\n                    <jats:italic>Trp53<\/jats:italic>\n                    allele loss can drive a sustained inflammatory, DNA damage and oxidative stress response that, over time, facilitate and support carcinogenesis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-021-03638-3","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T09:02:52Z","timestamp":1617699772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of I\u03baB\u03b1 expression"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura","family":"Marruecos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Manils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-3925","authenticated-orcid":false,"given":"Ingrid","family":"Filgaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-4099","authenticated-orcid":false,"given":"Llu\u00eds","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6502-5012","authenticated-orcid":false,"given":"Concepci\u00f3","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"3638_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s000180050265","volume":"55","author":"M Oren","year":"1999","unstructured":"Oren, M. & Rotter, V. Introduction p53: the first twenty years. Cell. Mol. Life Sci. 55, 9\u201311 (1999).","journal-title":"Cell. Mol. Life Sci."},{"key":"3638_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/sj.onc.1210263","volume":"26","author":"HF Horn","year":"2007","unstructured":"Horn, H. F. & Vousden, K. H. Coping with stress: multiple ways to activate p53. Oncogene 26, 1306\u20131316 (2007).","journal-title":"Oncogene"},{"key":"3638_CR3","first-page":"359","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Publ. Gr. 14, 359\u2013370 (2014).","journal-title":"Nat. Publ. Gr."},{"key":"3638_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-94-017-9211-0_18","volume":"85","author":"AV Budanov","year":"2014","unstructured":"Budanov, A. V. The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell. Biochem. 85, 337\u2013358 (2014).","journal-title":"Subcell. Biochem."},{"key":"3638_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","volume":"16","author":"F Kruiswijk","year":"2015","unstructured":"Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. P53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393\u2013405 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3638_CR6","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/carcin\/bgu134","volume":"35","author":"T Cooks","year":"2014","unstructured":"Cooks, T., Harris, C. C. & Oren, M. Caught in the cross fire: p53 in inflammation. Carcinogenesis 35, 1680\u20131690 (2014).","journal-title":"Carcinogenesis"},{"key":"3638_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-9255-11-23","volume":"11","author":"S Pal","year":"2014","unstructured":"Pal, S. et al. Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism. J. Inflamm. 11, 23 (2014).","journal-title":"J. Inflamm."},{"key":"3638_CR8","doi-asserted-by":"publisher","first-page":"a026161","DOI":"10.1101\/cshperspect.a026161","volume":"6","author":"AV Gudkov","year":"2016","unstructured":"Gudkov, A. V. & Komarova, E. A. P53 and the carcinogenicity of chronic inflammation. Cold Spring Harb. Perspect. Med. 6, a026161 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"3638_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1096\/fj.04-3213fje","volume":"19","author":"EA Komarova","year":"2005","unstructured":"Komarova, E. A. et al. p53 is a suppressor of inflammatory response in mice. FASEB J. 19, 1030\u20131032 (2005).","journal-title":"FASEB J."},{"key":"3638_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2337\/diabetes.54.5.1423","volume":"54","author":"SJ Zheng","year":"2005","unstructured":"Zheng, S. J., Lamhamedi-Cherradi, S. E., Wang, P., Xu, L. & Chen, Y. H. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 54, 1423\u20131428 (2005).","journal-title":"Diabetes"},{"key":"3638_CR11","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.4049\/jimmunol.0803526","volume":"182","author":"G Liu","year":"2009","unstructured":"Liu, G., Park, Y.-J., Tsuruta, Y., Lorne, E. & Abraham, E. p53 attenuates lipopolysaccharide-induced NF-\u03baB activation and acute lung injury. J. Immunol. 182, 5063\u20135071 (2009).","journal-title":"J. Immunol."},{"key":"3638_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccr.2013.03.022","volume":"23","author":"T Cooks","year":"2013","unstructured":"Cooks, T. et al. Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 23, 634\u2013646 (2013).","journal-title":"Cancer Cell"},{"key":"3638_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0002-9440(10)64356-8","volume":"160","author":"Y Yamanishi","year":"2002","unstructured":"Yamanishi, Y. et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am. J. Pathol. 160, 123\u2013130 (2002).","journal-title":"Am. J. Pathol."},{"key":"3638_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-5728(02)00428-9","volume":"135","author":"Y Okuda","year":"2003","unstructured":"Okuda, Y., Okuda, M. & Bernard, C. C. A. Regulatory role of p53 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 135, 29\u201337 (2003).","journal-title":"J. Neuroimmunol."},{"key":"3638_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992).","journal-title":"Nature"},{"key":"3638_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley, J. M. Germline TP53 mutations and Li-Fraumeni syndrome. Hum. Mutat. 21, 313\u2013320 (2003).","journal-title":"Hum. Mutat."},{"key":"3638_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1096\/fasebj.7.10.8344491","volume":"7","author":"M Harvey","year":"1993","unstructured":"Harvey, M., McArthur, M. J., Montgomery, C. A., Bradley, A. & Donehower, L. A. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7, 938\u2013943 (1993).","journal-title":"FASEB J."},{"key":"3638_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng1193-225","volume":"5","author":"M Harvey","year":"1993","unstructured":"Harvey, M. et al. Spontaneous and carcinogen\u2212induced tumorigenesis in p53\u2212deficient mice. Nat. Genet. 5, 225\u2013229 (1993).","journal-title":"Nat. Genet."},{"key":"3638_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1\u20137 (1994).","journal-title":"Curr. Biol."},{"key":"3638_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/019262301753178555","volume":"29","author":"S Venkatachalam","year":"2001","unstructured":"Venkatachalam, S. et al. Is p53 haploinsufficient for tumor suppression? Implications for the p53+\/\u2212 mouse model in carcinogenicity testing. Toxicol. Pathol. 29, 147\u2013154 (2001).","journal-title":"Toxicol. Pathol."},{"key":"3638_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nrc2731","volume":"9","author":"LA Donehower","year":"2009","unstructured":"Donehower, L. A. & Lozano, G. 20 years studying p53 functions in genetically engineered mice. Nat. Rev. Cancer 9, 831\u2013841 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"3638_CR22","first-page":"603","volume":"9","author":"CA Purdie","year":"1994","unstructured":"Purdie, C. A. et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603\u2013609 (1994).","journal-title":"Oncogene"},{"key":"3638_CR23","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1093\/emboj\/17.16.4657","volume":"17","author":"S Venkatachalam","year":"1998","unstructured":"Venkatachalam, S. et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657\u20134667 (1998).","journal-title":"EMBO J."},{"key":"3638_CR24","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0002-9440(10)64853-5","volume":"157","author":"C Kuperwasser","year":"2000","unstructured":"Kuperwasser, C. et al. Development of spontaneous mammary tumors in BALB\/c p53 heterozygous mice: a model for Li-Fraumeni syndrome. Am. J. Pathol. 157, 2151\u20132159 (2000).","journal-title":"Am. J. Pathol."},{"key":"3638_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/jmbi.1998.1897","volume":"281","author":"P Ch\u00e8ne","year":"1998","unstructured":"Ch\u00e8ne, P. In vitro analysis of the dominant negative effect of p53 mutants. J. Mol. Biol. 281, 205\u2013209 (1998).","journal-title":"J. Mol. Biol."},{"key":"3638_CR26","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","volume":"26","author":"A Petitjean","year":"2007","unstructured":"Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P. & Olivier, M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26, 2157\u20132165 (2007).","journal-title":"Oncogene"},{"key":"3638_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean, A. et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28, 622\u2013629 (2007).","journal-title":"Hum. Mutat."},{"key":"3638_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/path.2784","volume":"223","author":"AM Goh","year":"2011","unstructured":"Goh, A. M., Coffill, C. R. & Lane, D. P. The role of mutant p53 in human cancer. J. Pathol. 223, 116\u2013126 (2011).","journal-title":"J. Pathol."},{"key":"3638_CR29","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1038\/cddis.2017.80","volume":"8","author":"EM Alexandrova","year":"2017","unstructured":"Alexandrova, E. M. et al. P53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo. Cell Death Dis. 8, e2661 (2017).","journal-title":"Cell Death Dis"},{"key":"3638_CR30","first-page":"2449","volume":"8","author":"S Srivastava","year":"1993","unstructured":"Srivastava, S., Wang, S., Tong, Y. A., Pirollo, K. & Chang, E. H. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 8, 2449\u20132456 (1993).","journal-title":"Oncogene"},{"key":"3638_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12308-4","volume":"7","author":"J Manils","year":"2017","unstructured":"Manils, J. et al. Double deficiency of Trex2 and DNase1L2 nucleases leads to accumulation of DNA in lingual cornifying keratinocytes without activating inflammatory responses. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"3638_CR32","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1158\/0008-5472.CAN-09-1208","volume":"69","author":"D Parra","year":"2009","unstructured":"Parra, D. et al. Increased susceptibility to skin carcinogenesis in TREX2 knockout mice. Cancer Res. 69, 6676\u20136684 (2009).","journal-title":"Cancer Res."},{"key":"3638_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.etp.2006.01.007","volume":"57","author":"JM Ward","year":"2006","unstructured":"Ward, J. M. Lymphomas and leukemias in mice. Exp. Toxicol. Pathol. 57, 377\u2013381 (2006).","journal-title":"Exp. Toxicol. Pathol."},{"key":"3638_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 49, 1603\u20131616 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"3638_CR35","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1089\/ars.2010.3644","volume":"15","author":"D Liu","year":"2011","unstructured":"Liu, D. & Xu, Y. P53, oxidative stress, and aging. Antioxid. Redox Signal. 15, 1669\u20131678 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"3638_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.abb.2018.01.004","volume":"640","author":"Y Aratani","year":"2018","unstructured":"Aratani, Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys. 640, 47\u201352 (2018).","journal-title":"Arch. Biochem. Biophys."},{"key":"3638_CR37","doi-asserted-by":"publisher","first-page":"C441","DOI":"10.1152\/ajpcell.2001.280.3.C441","volume":"280","author":"ED Chan","year":"2001","unstructured":"Chan, E. D. & Riches, D. W. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK\/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol 280, C441\u201350 (2001).","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"3638_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/08830185.2012.755176","volume":"32","author":"Y Yang","year":"2013","unstructured":"Yang, Y., Bazhin, A. V., Werner, J. & Karakhanova, S. Reactive oxygen species in the immune system. Int. Rev. Immunol. 32, 249\u2013270 (2013).","journal-title":"Int. Rev. Immunol."},{"key":"3638_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1012544","volume":"94","author":"S Dupr\u00e9-Crochet","year":"2013","unstructured":"Dupr\u00e9-Crochet, S., Erard, M. & N\u00fc\u03b2e, O. ROS production in phagocytes: why, when, and where? J. Leukoc. Biol. 94, 657\u2013670 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"3638_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/hsz-2013-0241","volume":"395","author":"J Lugrin","year":"2014","unstructured":"Lugrin, J., Rosenblatt-Velin, N., Parapanov, R. & Liaudet, L. The role of oxidative stress during inflammatory processes. Biol. Chem. 395, 203\u2013230 (2014).","journal-title":"Biol. Chem."},{"key":"3638_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/hsz-2013-0241","volume":"395","author":"J Lugrin","year":"2014","unstructured":"Lugrin, J., Rosenblatt-Velin, N., Parapanov, R. & Liaudet, L. The role of oxidative stress during inflammatory processes. Biol. Chem. 395, 203\u2013230 (2014).","journal-title":"Biol. Chem."},{"key":"3638_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"3638_CR43","first-page":"149","volume":"11","author":"RK Geyer","year":"2000","unstructured":"Geyer, R. K., Nagasawa, H., Little, J. B. & Maki, C. G. Role and regulation of p53 during an ultraviolet radiation-induced G1 cell cycle arrest. Cell Growth Differ. 11, 149\u2013156 (2000).","journal-title":"Cell Growth Differ."},{"key":"3638_CR44","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1038\/sj.onc.1204883","volume":"20","author":"L Latonen","year":"2001","unstructured":"Latonen, L., Taya, Y. & Laiho, M. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20, 6784\u20136793 (2001).","journal-title":"Oncogene"},{"key":"3638_CR45","doi-asserted-by":"publisher","first-page":"e75800","DOI":"10.1371\/journal.pone.0075800","volume":"8","author":"GD Mcfeat","year":"2013","unstructured":"Mcfeat, G. D., Allinson, S. L. & Mcmillan, T. J. Characterisation of the p53-mediated cellular responses evoked in primary mouse cells following exposure to ultraviolet radiation. PLoS ONE 8, e75800 (2013).","journal-title":"PLoS ONE"},{"key":"3638_CR46","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1038\/sj.onc.1209387","volume":"25","author":"CJ Lynch","year":"2006","unstructured":"Lynch, C. J. & Milner, J. Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency. Oncogene 25, 3463\u20133470 (2006).","journal-title":"Oncogene"},{"key":"3638_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.cb.10.110194.002201","volume":"10","author":"U Siebenlist","year":"1994","unstructured":"Siebenlist, U., Franzoso, G. & Brown, K. Structure, regulation and function of NF-kappaB. Annu. Rev. Cell Biol. 10, 405\u2013455 (1994).","journal-title":"Annu. Rev. Cell Biol."},{"key":"3638_CR48","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858\u20135868 (1998).","journal-title":"J. Biol. Chem."},{"key":"3638_CR49","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-\u03baB activity. Annu. Rev. Immunol. 18, 621\u2013663 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"3638_CR50","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.1073\/pnas.0604085103","volume":"103","author":"S Krishna","year":"2006","unstructured":"Krishna, S., Jensen, M. H. & Sneppen, K. Minimal model of spiky oscillations in NF-\u03baB signaling. Proc. Natl Acad. Sci. USA 103, 10840\u201310845 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3638_CR51","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/MCB.15.5.2689","volume":"15","author":"F Arenzana-Seisdedos","year":"1995","unstructured":"Arenzana-Seisdedos, F. et al. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 15, 2689\u20132696 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"3638_CR52","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.8096091","volume":"259","author":"SC Sun","year":"1993","unstructured":"Sun, S. C., Ganchi, P. A., Ballard, D. W. & Greene, W. C. NF-\u03baB controls expression of inhibitor I\u03baB\u03b1: evidence for an inducible autoregulatory pathway. Science 259, 1912\u20131915 (1993).","journal-title":"Science"},{"key":"3638_CR53","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.18632\/oncotarget.2545","volume":"5","author":"A Bisio","year":"2014","unstructured":"Bisio, A. et al. Cooperative interactions between p53 and NF\u03baB enhance cell plasticity. Oncotarget 5, 12111\u201312125 (2014).","journal-title":"Oncotarget"},{"key":"3638_CR54","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1101\/gad.8.15.1739","volume":"8","author":"Y Barak","year":"1994","unstructured":"Barak, Y., Gottlieb, E., Juven-Gershon, T. & Oren, M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8, 1739\u20131749 (1994).","journal-title":"Genes Dev."},{"key":"3638_CR55","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1093\/emboj\/cdf595","volume":"21","author":"I Garc\u00eda-Cao","year":"2002","unstructured":"Garc\u00eda-Cao, I. et al. \u2018Super p53\u2019 mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225\u20136235 (2002).","journal-title":"EMBO J."},{"key":"3638_CR56","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature05949","volume":"448","author":"A Matheu","year":"2007","unstructured":"Matheu, A. et al. Delayed ageing through damage protection by the Arf\/p53 pathway. Nature 448, 375\u2013379 (2007).","journal-title":"Nature"},{"key":"3638_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1947601911413466","volume":"2","author":"D Malkin","year":"2011","unstructured":"Malkin, D. Li-fraumeni syndrome. Genes Cancer 2, 475\u2013484 (2011).","journal-title":"Genes Cancer"},{"key":"3638_CR58","doi-asserted-by":"publisher","first-page":"a026187","DOI":"10.1101\/cshperspect.a026187","volume":"7","author":"T Guha","year":"2017","unstructured":"Guha, T. & Malkin, D. Inherited TP53 mutations and the Li-fraumeni syndrome. Cold Spring Harb. Perspect. Med 7, a026187 (2017).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"3638_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/CCO.0b013e328333bf00","volume":"22","author":"EI Palmero","year":"2010","unstructured":"Palmero, E. I., Achatz, M. I., Ashton-Prolla, P., Olivier, M. & Hainaut, P. Tumor protein 53 mutations and inherited cancer: Beyond Li-Fraumeni syndrome. Curr. Opin. Oncol. 22, 64\u201369 (2010).","journal-title":"Curr. Opin. Oncol."},{"key":"3638_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233\u20131238 (1990).","journal-title":"Science"},{"key":"3638_CR61","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.onc.1202033","volume":"17","author":"JM Birch","year":"1998","unstructured":"Birch, J. M. et al. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17, 1061\u20131068 (1998).","journal-title":"Oncogene"},{"key":"3638_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2013.09.008","volume":"356","author":"CN Sprung","year":"2015","unstructured":"Sprung, C. N. et al. Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. Cancer Lett. 356, 72\u201381 (2015).","journal-title":"Cancer Lett."},{"key":"3638_CR63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0885-3924(00)00199-8","volume":"20","author":"RJ Dunlop","year":"2000","unstructured":"Dunlop, R. J. & Campbell, C. W. Cytokines and advanced cancer. J. Pain Symptom Manag. 20, 214\u2013232 (2000).","journal-title":"J. Pain Symptom Manag."},{"key":"3638_CR64","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","volume":"96","author":"V Hoffacker","year":"2000","unstructured":"Hoffacker, V. et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96, 3872\u20133879 (2000).","journal-title":"Blood"},{"key":"3638_CR65","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nm1320","volume":"11","author":"AA Sablina","year":"2005","unstructured":"Sablina, A. A. et al. The antioxidant function of the p53 tumor suppressor. Nat. Med. 11, 1306\u20131313 (2005).","journal-title":"Nat. Med."},{"key":"3638_CR66","doi-asserted-by":"publisher","first-page":"e47010","DOI":"10.1371\/journal.pone.0047010","volume":"7","author":"GS Macedo","year":"2012","unstructured":"Macedo, G. S. et al. Increased oxidative damage in carriers of the germline TP53 p.R337H mutation. PLoS ONE 7, e47010 (2012).","journal-title":"PLoS ONE"},{"key":"3638_CR67","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1214091","volume":"368","author":"PY Wang","year":"2013","unstructured":"Wang, P. Y. et al. Increased oxidative metabolism in the Li-Fraumeni syndrome. N. Engl. J. Med. 368, 1027\u20131032 (2013).","journal-title":"N. Engl. J. Med."},{"key":"3638_CR68","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri.2016.99","volume":"16","author":"C Mu\u00f1oz-Fontela","year":"2016","unstructured":"Mu\u00f1oz-Fontela, C., Mandinova, A., Aaronson, S. A. & Lee, S. W. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat. Rev. Immunol. 16, 741\u2013750 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"3638_CR69","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/onc.2016.502","volume":"36","author":"M Fischer","year":"2017","unstructured":"Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943\u20133956 (2017).","journal-title":"Oncogene"},{"key":"3638_CR70","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1084\/jem.20121674","volume":"210","author":"JH Madenspacher","year":"2013","unstructured":"Madenspacher, J. H. et al. p53 integrates host defense and cell fate during bacterial pneumonia. J. Exp. Med. 210, 891\u2013904 (2013).","journal-title":"J. Exp. Med."},{"key":"3638_CR71","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4049\/jimmunol.1201716","volume":"191","author":"ME Spehlmann","year":"2013","unstructured":"Spehlmann, M. E. et al. Trp53 deficiency protects against acute intestinal inflammation. J. Immunol. 191, 837\u2013847 (2013).","journal-title":"J. Immunol."},{"key":"3638_CR72","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1158\/0008-5472.CAN-13-1070","volume":"74","author":"JM Lowe","year":"2014","unstructured":"Lowe, J. M. et al. P53 and NF-\u03baB coregulate proinflammatory gene responses in human macrophages. Cancer Res. 74, 2182\u20132192 (2014).","journal-title":"Cancer Res."},{"key":"3638_CR73","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/nm1205-1278","volume":"11","author":"K Bensaad","year":"2005","unstructured":"Bensaad, K. & Vousden, K. H. Savior and slayer: the two faces of p53. Nat. Med. 11, 1278\u20131279 (2005).","journal-title":"Nat. Med."},{"key":"3638_CR74","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1947601911409747","volume":"2","author":"AV Gudkov","year":"2011","unstructured":"Gudkov, A. V., Gurova, K. V. & Komarova, E. A. Inflammation and p53: a tale of two stresses. Genes Cancer 2, 503\u2013516 (2011).","journal-title":"Genes Cancer"},{"key":"3638_CR75","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1074\/jbc.M106607200","volume":"277","author":"NS Chang","year":"2002","unstructured":"Chang, N. S. The non-ankyrin C terminus of I\u03baB\u03b1 physically interacts with p53 in Vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-\u03b21-mediated growth suppression. J. Biol. Chem. 277, 10323\u201310331 (2002).","journal-title":"J. Biol. Chem."},{"key":"3638_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2172-6-12","volume":"6","author":"DH Dreyfus","year":"2005","unstructured":"Dreyfus, D. H., Nagasawa, M., Gelfand, E. W. & Ghoda, L. Y. Modulation of p53 activity by I\u03baB\u03b1: evidence suggesting a common phylogeny between NF-\u03baB and p53 transcription factors. BMC Immunol. 6, 12 (2005).","journal-title":"BMC Immunol."},{"key":"3638_CR77","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1096\/fj.10-160549","volume":"24","author":"P Ak","year":"2010","unstructured":"Ak, P. & Levine, A. J. p53 and NF\u2010\u03baB: different strategies for responding to stress lead to a functional antagonism. FASEB J. 24, 3643\u20133652 (2010).","journal-title":"FASEB J."},{"key":"3638_CR78","doi-asserted-by":"publisher","first-page":"26115","DOI":"10.1074\/jbc.M313509200","volume":"279","author":"J Bohuslav","year":"2004","unstructured":"Bohuslav, J., Chen, L. F., Kwon, H., Mu, Y. & Greene, W. C. p53 induces NF-\u03baB activation by an I\u03baB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279, 26115\u201326125 (2004).","journal-title":"J. Biol. Chem."},{"key":"3638_CR79","doi-asserted-by":"publisher","first-page":"27549","DOI":"10.1074\/jbc.M313435200","volume":"279","author":"S Fujioka","year":"2004","unstructured":"Fujioka, S. et al. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-\u03baB. J. Biol. Chem. 279, 27549\u201327559 (2004).","journal-title":"J. Biol. Chem."},{"key":"3638_CR80","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12864-018-5211-y","volume":"19","author":"K Szoltysek","year":"2018","unstructured":"Szoltysek, K. et al. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-\u03baB and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genom. 19, 813 (2018).","journal-title":"BMC Genom"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03638-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03638-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03638-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T03:48:00Z","timestamp":1669952880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03638-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["3638"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03638-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"5 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All mice procedures were performed in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"359"}}